Delayed type hypersensitivity (DTH): DTH in 13 out of 15 patients IFN-γ ELISpot: Autologous tumour cells recognizing circulating T cells were revealed to be more frequent in patients who clinically benefited from the therapy. Here, IFNG is linked to neoplasm.